MedTrace Logo

Moringa Powder Acceptability Trial Among Healthy Adults

NCT05861076 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2025-01-01

No results posted yet for this study

Summary

The study is a randomized acceptability trial involving the provision of three different doses of Moringa powder to be consumed daily by study participants.

Conditions

  • Consumption
  • Acceptability
  • Side Effect

Interventions

OTHER

Moringa Powder - Low Dose

1 teaspoon Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days

OTHER

Moringa Powder - Medium Dose

2 teaspoons Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days

OTHER

Moringa Powder - High Dose

3 teaspoons Moringa leaf powder to be consumed with usual food and/or drinks daily for 7 days

Sponsors & Collaborators

Principal Investigators

  • Susana Matias, PhD · University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2023-05-11
Completion
2023-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05861076 on ClinicalTrials.gov